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B-cell antigen receptor diversity is achieved by 
the assembly of antibody gene segments through 
V(D)J recombination (1). The random nature of 
the recombination process leads to the unavoid-
able production of self-reactive specifi  cities, 
which are silenced both centrally and periph-
erally by clonal deletion, anergy, and receptor 
  editing (2–6). Despite these mechanisms of tol-
erance, autoantibodies are frequently detected 
in normal mice (7, 8), and recent estimates 
  suggest that up to 20% of long-lived B cells are 
self-reactive in humans (9). Although the ex-
act mechanism by which these lymphocytes es-
cape elimination is unknown, experiments with 
transgenic mice carrying prerecombined auto-
antibodies suggest that some self-reactive speci-
fi  cities may persist in the B-cell compartment 
by coexpression of a second “innocuous” light 
chain on the cell surface, a phenomenon re-
ferred to as allelic inclusion (10–12). Coexpres-
sion of a non–self-reactive light chain is thought 
to rescue the B cell from negative selection by 
diluting the self-reactive receptor (13). How-
ever, the presence of B cells bearing two re-
ceptors in transgenic mice poses a challenge to 
the mechanism of allelic exclusion (14–17), as 
well as to the “one lymphocyte–one antibody” 
theory (18). Thus, the extent and function of 
light chain allelic inclusion under physiological 
conditions is unknown.
Until recently, the study of light chain gene 
recombination at the κ loci was hampered by a 
lack of natural κ allelic polymorphisms in hu-
mans or mice. To overcome this diffi   culty, we 
used gene targeting to replace the mouse Igκ 
constant region (mCκ) with its human coun-
terpart (hCκ; references 19, 20). Using mice 
heterozygous for the hCκ allele (Igκm/h), we 
showed that  3–5% of B lymphocytes express 
equal amounts of cell surface mCκ and hCκ 
light chains, as measured by fl  ow  cytometry 
(reference 19; Fig. 1 A, mCκ+hCκ+ population). 
This analysis, however, failed to consider allelic 
inclusion within mCκ−hCk+ or mCk+hCk− 
B-cell populations (Fig. 1 A), which might 
conceal Igκ double producers expressing pre-
dominantly one of two light chains on the cell 
surface. We determined the full extent of allelic 
inclusion in the B-cell compartment of Igκm/h 
mice by several independent assays. We show 
that  10% of B lymphocytes express two cell 
surface receptors. Moreover, we demonstrate 
that these double producers arise from light 
chain editing, and not as a result of defects in 
the mechanism of allelic exclusion.
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The discovery of lymphocytes bearing two light chains in mice carrying self-reactive anti-
body transgenes has challenged the “one lymphocyte–one antibody” rule. However, the 
extent and nature of allelically included cells in normal mice is unknown. We show that 
10% of mature B cells coexpress both Igκ alleles. These cells are not the result of failure in 
allelic exclusion per se, but arise through receptor editing. We fi  nd that under physiological 
conditions, editing occurs both by deletion and by inclusion with equal probability. In 
addition, we demonstrate that B lymphocytes carrying two B-cell receptors are recruited 
to germinal center reactions, and thus fully participate in humoral immune responses. Our 
data measure the scope of allelic inclusion and provide a mechanism whereby autoreactive 
B cells might “escape” central tolerance.
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RESULTS
B lymphocytes frequently express two cell surface receptors
To measure the scope of allelic inclusion, we fi  rst stained 
Igκm/h splenic B cells with anti-hCκ and -mCκ antibodies 
and characterized light chain transcripts in single cells by RT-
PCR and sequencing (9). In agreement with our previous 
observations (19), VJκ-mCκ and -hCκ transcripts were read-
ily detected in mCκ+hCκ+ lymphocytes. These cells make 
up 3–5% of the total B-cell pool, and most express in-frame 
transcripts from both alleles (Fig. 1 A and Table S1, available 
at http://www.jem.org/cgi/content/full/jem.20061918/DC1; 
183/195 in-frame). VJκ-mCκ mRNAs were detected in 
 30% (37/126) of apparently single-positive mCκ−hCκ+ 
B cells, but only one third of these transcripts (10/37) were 
in-frame (Fig. 1 A). Likewise, hCκ+ transcripts were present 
at a similar frequency in mCκ+hCκ− B cells (Fig. 1 A, 
35/126; 10 in-frame). Analysis of a control mixture of Igκm/m 
and Igκh/h lymphocytes demonstrated that <0.5% of the ana-
lyzed cells might be improperly scored as dual κ producers by 
this method. Taking into account the effi   ciency of the PCR 
reaction, we conclude that 11% of all B lymphocytes in Igκm/h 
mice express in-frame light chain transcripts from both κ 
  alleles (4% of the hCκ+mCκ− cells + 4% of the hCκ−mCκ+ 
cells + 3% of the hCκ+mCκ+ cells; Table S1).
To measure the extent of allelic inclusion at the protein 
level, isolated Igκm/h splenic B cells were stained with anti-hCκ 
(Fig. 1 B, red, Alexa Fluor 546) and anti-mCκ (green, Alexa 
Fluor 488) antibodies and characterized by confocal micros-
copy. The specifi  city of this staining was assessed in B cells iso-
lated from Igκm/m and Igκh/h mice, from which  1 in 250 cells 
were nonspecifi  cally recognized by both antibodies. Of 1,710 
individual B cells analyzed, we found that 123 (7.2%) coex-
pressed detectable levels of mouse and human Cκ light chains 
on the cell surface (Fig. 1 B). However, the intensity of staining 
varied between alleles, with some cells staining predominantly 
with anti-mCκ and others with anti-hCκ (Fig. 1 B, middle 
and right, and Fig. S1 available at http://www.jem.org/cgi/ 
content/full/jem.20061918/DC1). Finally, we produced hy-
bridomas from Igκm/h splenic lymphocytes and measured mCκ 
and hCκ light chain protein production. Of 128 hybridomas 
screened by ELISA and Western blotting, 12% were found to 
be allelically included, with 4% (5/128) secreting high levels of 
both mCκ and hCκ light chains (Fig. 1 C, B47), whereas the 
remaining 8% (10/128) predominantly expressed one of two 
alleles (Fig. 1 C, sample A32). The divergent pattern of cell 
surface mCκ/hCκ expression observed in the latter population 
was a direct correlation of Igκ transcription levels (Fig. S2), and 
may refl  ect inherent diff  erences in Vκ promoter strength (20). 
Therefore, based on single-cell PCR, confocal microscopy, 
and hybridoma analyses, we conclude that  10% of peripheral 
B lymphocytes are allelically included, indicating that B cells 
frequently develop expressing two B-cell surface receptors.
Allelic inclusion results from light chain receptor editing
At least two mechanisms could account for dual κ light 
chain expression. Secondary VJκ rearrangements might be 
Figure 1.  Allelic inclusion in Igκm/h mice. (A) Left pseudocolor plot 
shows analysis of mouse and human κ expression in Igκm/h splenocytes 
gated on B220+Igλ− and stained with rat monoclonal antibodies against 
mCκ and hCκ. Numbers indicate percentages of gated lymphocytes. VJκ-
mCκ and -hCκ transcripts (top schematics) were amplifi  ed by RT-PCR 
from single cells sorted from mCκ+, hCκ+, and mCκ+hCκ+ fractions. Numbers 
in parentheses represent percentage of in-frame transcripts amplifi  ed 
from the various fractions of total B220+ B cells (a more detailed analysis 
is given in Table S1). TO-PRO3 was used to exclude dead cells from analysis. 
(B) Igκ protein expression in Igκm/h lymphocytes. Total splenic B cells 
were enriched by magnetic bead depletion of nonB cells and stained with 
anti-hCκ (red, Alexa Fluor 546) and anti-mCκ (green, Alexa Fluor 488). 
Cells were cytospun and analyzed by confocal microscopy. Values were 
summed from two independent experiments (1,192 and 518 cells scored). 
This analysis was also reproduced using a colorimetric assay on additional 
mice (Fig. S1). (C) mCκ and hCκ expression in 15 allelically included Igκm/h 
hybridomas (from a total of 128), as determined by fl  ow cytometry (contour 
plots) and Western blot (insets). Control staining included splenocytes from 
Igκm/m and Igκh/h mice (fi  rst two plots). Fig. S1 and Table S1 are available 
at http://www.jem.org/cgi/content/full/jem.20061918/DC1). JEM VOL. 204, January 22, 2007  155
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specifi  cally induced to abolish self-reactivity or to rescue 
cells carrying less than optimal combinations of Ig heavy and 
light chains. Alternatively, ineffi   cient allelic exclusion could 
lead to primary V–J recombination on both κ alleles. To 
discriminate between these two possibilities, we compared 
the developmental kinetics of bone marrow B cells carrying 
one or two κ light chains by BrdU labeling in vivo. The 
thymidine analogue BrdU is incorporated in the genome of 
cycling proB cells that give rise to the small resting preB 
cells in which light chains are actively rearranged (21). Ed-
ited B lymphocytes are developmentally delayed compared 
with unedited cells in this assay (19). In agreement with 
published observations (19, 22, 23), BrdU+B220low B cells 
expressing only mCκ or hCκ emerged fi  rst into the imma-
ture B-cell compartment,  4 h after BrdU injection (Fig. 
2 A). In contrast, allelically included lymphocytes were de-
layed at the preB-cell stage for at least an additional 4 h, 
  appearing in the IgM+ immature B-cell compartment 8 h 
after BrdU injection (Fig. 2 A). This developmental delay 
suggests that dual receptor expression is not the result of 
  simultaneous biallelic Igκ recombination or failure in allelic 
exclusion, but instead, results from secondary light chain gene 
rearrangements in cells arrested at the early preB-cell stage 
of development.
Increased downstream Jκ usage has been associated with 
receptor editing, as it suggests continuing V–Jκ rearrange-
ments (24). Our analysis of 401 antibody sequences obtained 
from Igκm/h primary cells and hybridomas showed that Jκ1 
usage is predominant in allelically excluded cells (35% vs. 20%; 
χ2 test, P = 0.002; Fig. 2 B). In contrast, Jκ5 was   signifi  cantly 
enriched in cells carrying dual receptors (21% vs. 34%; χ2 test, 
P = 0.005; Fig. 2 B). This observation further reinforces the 
conclusion that allelic inclusion occurs in cells undergoing ex-
tensive light chain editing, presumably because of self-reactivity. 
To examine whether allelically included lymphocytes carry 
autoreactive receptors, we tested individual antibodies from 
Igκ-included (15 clones) and -excluded (38 clones) hybrid-
omas for binding to double-stranded DNA or HEp-2 cells, 
which are commonly used to diagnose autoimmune diseases 
such as lupus (25). We found that >30% of mCκ+hCκ+ 
cells carried self-reactivity conferred predominantly by either 
the human or the mouse light chain (Fig. 2 C). Autoreactivity 
in these clones was confi  rmed using a test for mouse anti-
nuclear antigen (ANA) reactivity (see Materials and methods). 
Figure 2.  Allelically included B cells result from receptor editing. 
(A) Kinetics of bone marrow development of included and excluded B cells. 
Linear regression analysis shows the percentage of B220lowBrdU+ B cells 
plotted against time. Percentage values of excluded mCκ+ (blue ovals) and 
hCκ+ (green squares) cells are represented in the left y axis, and the per-
centage of mCκ+hCκ+-included cells (red circles) is depicted in the right 
y axis. Igκm/h mice were injected with 0.5 mg of BrdU intraperitoneally and 
killed after 6, 12, 18, 24, and 48 h (three mice per time point). Cells were 
permeabilized and stained with anti–BrdU-APC, mCκ-PE, hCκ-FITC, and 
B220-PerCP antibodies. (B) Comparative analysis of Jκ usage (percentage) 
in allelically included (red bars; n = 168 transcripts) and excluded (blue 
bars; n = 233 transcripts) B cells. (C) Antibodies purifi  ed from the super-
natants of 15 mCκ+hCκ+ hybridoma clones were compared with 38 anti-
bodies from hybridomas expressing only one allele for binding to HEp-2 
cells and double-stranded DNA. HEp-2 binding was compared with positive 
and negative control sera provided by the manufacturer. To ensure HEp-2 
binding was not caused by xenoreactivity, self-specifi  cities were verifi  ed 
by a commercial ANA assay designed for mice (not depicted).156  ALLELIC INCLUSION RESULTS FROM EDITING | Casellas et al.
Self-reactivity in allelically excluded cells was nearly three-
fold less frequent (13%) than in hybridomas expressing dual 
receptors, although the low number of included hybridomas 
precluded a suffi   cient n-value to reach statistical signifi  cance 
(χ2 test, P = 0.09). Collectively, our data indicate that recep-
tor editing leads to light chain allelic inclusion and retention 
of self-specifi  cities in the B-cell compartment.
Allelically included B cells preferentially home to MZs 
and can contribute to immune responses
B cells carrying natural autoantibodies have been shown to 
accumulate preferentially in the marginal zone (MZ) of mice 
(26), but not of humans (27). To investigate the distribution of 
Igκ-included cells in the long-lived B-cell compartment, we 
assessed mCκ and hCκ expression in Igκm/h spleens by immuno-
histochemistry, fl  ow cytometry, and single-cell PCR. We 
found allelically included cells both within the follicles and 
MZs (Fig. 3 A). However, whereas between 8–11% of fol-
licular B cells (B220+CD23highCD21low) were mCκ+hCκ+, 
 20% of MZ lymphocytes (B220+CD23lowCD21high) ex-
pressed light chains from both alleles (Fig. 3 B; χ2 test, 
P < 0.0001). Preferential homing of Igκ double producers 
to MZs is consistent with the reported accumulation of 
edited Igκ+Igλ+ lymphocytes in MZs of anti-DNA transgenic 
Figure 3.  Allelically included B cells home preferentially to MZs 
and participate in the germinal center reaction. (A) Control spleen 
sections from Igκm/m and Igκh/h mice (fi  rst and second images, respectively) 
were stained with antibodies against mCκ (blue) and hCκ (brown). 
  Allelically included cells (dark brown) are identifi  ed with arrowheads. 
(B) Frequency of included lymphocytes in follicular, MZ, and IgG+ B cell pop-
ulations, as determined by fl  ow cytometry (FC), immunohistochemistry 
(IHC), and single-cell PCR (SC-PCR). (C) To permanently tag the progeny 
of germinal center cells, mice expressing the Cre recombinase gene under 
the AID promoter were crossed to Rosa-neo-YFP transgenic mice (schematic). 
In AID-Cre-YFP mice B220+CD95high, germinal center B cells are 
  permanently labeled with YFP (1% of total B220+), and recirculating 
postgerminal center cells are identifi  ed as B220+CD95−YFP+ (0.2% 
of B220+, left pseudocolor plot). Allelic inclusion is assessed in post-
germinal center Igκm/h cells (1.2%, right pseudocolor plot). Mutation 
analysis of JH4 intron from B220+CD95−YFP+ postgerminal center 
and B220+CD95highAID−/− germinal center cells is shown with pie charts. 
Segment sizes in the pie charts are proportional to the number of 
  sequences carrying the number of mutations indicated in the periphery of 
the charts. The frequency of mutations per base pair sequenced and the 
total number of independent sequences analyzed is indicated underneath 
and in the center of each chart, respectively. Statistical signifi  cance was 
determined by a two-tailed Student’s t test assuming unequal variance 
and comparing to AID−/−.JEM VOL. 204, January 22, 2007  157
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mice (10). These results further suggest that included B cells 
often retain self-specifi  cities in Igκm/h mice, as reported in 
transgenic mice carrying autoantibodies (10–13).
To investigate whether Igκ double producers participate 
in the humoral immune response, we analyzed IgG+ B cells 
from Igκm/h mice. We readily found IgG+ lymphocytes 
that were mCκ+hCκ+ (2–5%; Fig. 3 B). To confi  rm the 
presence of allelically included cells in the postgerminal 
center B-cell compartment, we analyzed memory B cells 
in Igκm/hAID-Cre-yellow fl   uorescent protein (YFP) mice. 
In these mice, germinal center and memory B cells are indel-
ibly labeled with YFP (Fig. 3 C, left pseudocolor plot; 
  unpublished data). Flow cytometry analysis showed the pres-
ence of allelically included cells within postgerminal center 
CD95−YFP+ cells, which carry high levels of somatic hyper-
mutation (Fig. 3 C). These results demonstrate that B cells 
expressing two cell surface receptors are not excluded from 
the germinal center reaction and fully participate in the hu-
moral immune response.
Editing occurs by deletion and inclusion 
with similar probability
Using mice carrying prerecombined light chains, we estab-
lished that 25% of all developing B cells undergo light 
chain editing (19). To measure the extent of allelic inclusion 
within the edited compartment, we analyzed mice carrying a 
VκαHEL-Jκ2–targeted transgene and the hCκ allele (IgκαHEL/h 
mice). In these mice, the prerearranged light chain is nor-
mally paired to the physiological heavy chain repertoire, and 
V–Jκ replacements at the hCκ allele are readily monitored by 
fl  ow cytometry or PCR analysis (19). Single B cells were 
sorted from IgκαHEL/h mice and mCκ+ and hCκ+ transcripts 
were analyzed by single-cell PCR. We found that 61% of all 
developing B cells in these mice express the prerecombined 
αHEL light chain (Fig. 4 A). However, in  18% of all 
IgκαHEL/h B lymphocytes, the VκαHEL was edited by dele-
tion, either through nested recombination events at the mCκ 
allele alone (αHEL−mCκ+, 6%; Fig. 4 A), or together with 
recombination at the hCκ allele (αHEL−hCκ+, 12%; Fig. 
4 A). In close agreement with results obtained with Igκm/h 
mice (Figs. 1 and 2), editing by inclusion occurred in 14% of 
IgκαHEL/h B cells. The majority (13%) of these lymphocytes 
retained the VκαHEL light chain and carried in-frame V–J 
rearrangements at the hCκ allele (αHEL+hCκ+; Fig. 4 A), 
whereas a small number (1%) edited the VκαHEL by func-
tional rearrangements in both alleles (αHEL−hCκ+mCκ+; 
Fig. 4 A). In addition, we noted that nearly all rearrange-
ments at the hCk allele were in-frame (Fig. 4 B; 95%), which 
contrasts to the 2:1 OOF/in-frame ratio expected from ran-
dom recombination. This observation indicates that cells car-
rying successful V–Jκ rearrangements on the human allele 
were selected during development. Because hCκ+ B cells are 
developmentally delayed by editing in these mice (19), these 
results argue that allelic inclusion in IgκαHEL/h mice originates 
from secondary gene rearrangements and not as a result of 
defective exclusion of light chain gene recombination. We 
conclude that receptor editing occurs either by deletion or by 
allelic inclusion with roughly equal probability (Fig. 4).
D  I  S  C  U  S  S  I  O  N 
Studies with immunoglobulin knock-in mice suggested that 
autoreactive B cells are edited primarily by deletional recom-
bination (28, 29). However, the preference for deletion in auto-
immune mouse models might refl  ect the diffi   culty of vetoing 
somatically hypermutated receptors, which recognize auto-
antigens with high affi   nity and are not normally found in devel-
oping B cells (2, 4). Indeed, Ig light chain editing of naturally 
occurring antiself antibodies is less stringent (30). We show 
that under physiological conditions, editing occurs both by 
deletion and by allelic inclusion with nearly equal probability. 
Mechanistically, an equivalent deletion/inclusion ratio implies 
that although V–Jκ rearrangements initially target a single al-
lele, ensuring allelic exclusion in most cells (Fig. 4; references 
14–16, 31), autoreactivity and/or a 4-h developmental delay at 
the preB-cell stage promotes RAG accessibility to both alleles. 
This idea is consistent with recent fi  ndings showing that acti-
vation of both κ alleles is favored as development progresses 
from the preB to the immature B-cell stages (32).
Figure 4.  Extent of allelic inclusion in the edited B-cell compartment. 
(A) IgκαHEL/h splenic B cells were isolated by single-cell sorting, and 
387 Igκ transcripts were amplifi  ed by RT-PCR and analyzed by sequencing 
(top). From this analysis, six populations were characterized as shown 
(bottom). The VκαHEL prerecombined light chain is depicted by a yellow 
rectangle, and secondary recombination events at the mCκ and hCκ 
  alleles are depicted with red or blue rectangles, respectively. OOF rearrange-
ments are depicted by rectangles with a slash, and use of the lambda 
locus is represented with a green rectangle. (B) Analysis of in-frame and 
OOF status of Igκ transcripts in IgκαHEL/h or Igκm/h B cells. IgκαHEL/h cells 
were the same as those shown in A.158  ALLELIC INCLUSION RESULTS FROM EDITING | Casellas et al.
Although natural autoantibodies were discovered >100 yr 
ago (33), their origin has remained obscure. In normal in-
dividuals, large numbers of self-specifi  cities are believed to 
escape or bypass imperfect B-cell tolerance checkpoints (10), 
and this phenomenon appears to be exacerbated in patients 
with autoimmune diseases such as systemic lupus erythema-
tosus (8, 9, 34). Our studies suggest that light chain receptor 
editing, which normally accounts for 25–50% of all antibod-
ies (19, 35), also retains autoantibodies in the wild-type rep-
ertoire by allelic inclusion. As previously proposed (10, 11, 
13), coexpression of an innocuous receptor might dampen 
signaling from self-reactive receptors, and thus promote de-
velopment. Alternatively, light chain editors may tolerize auto-
reactive B cells by outcompeting self-reactive light chains 
for pairing with the IgH chain. This feature may, in fact, 
  explain the higher frequency of allelic inclusion as measured 
by single-cell RT-PCR analysis (11%; Fig. 1 A), which de-
tects Igκ transcription, versus confocal microscopy (7.2%; 
Fig. 1 B), which monitors light chain cell surface expression. 
Another possibility is that autoreactive receptors are continu-
ously internalized by autoantigen binding, as shown in B 
lymphocytes expressing anti-MHC antibodies (11) or in T 
cells expressing two α chains (36), although whether double-
producer T cells arise from a lack of α chain allelic exclusion 
or through receptor editing is still controversial (37).
The accumulation of allelically included B cells in MZs is 
intriguing. MZ B cells are commonly hyperreactive to T 
cell–independent type II antigens, such as phosphorylcho-
line, and represent the fi  rst line of defense against blood-
borne pathogens (38). Conceivably, self-reactive allelically 
included cells are preferentially selected into the MZ because 
of their chronic activation by self-antigens. Diversion to this 
compartment might help prevent these cells from undergo-
ing full cell diff  erentiation (10). If recruited to germinal cen-
ters, allelically included cells could, in fact, function as Trojan 
horses; by introducing stop codons or otherwise disabling the 
innocuous editor light chain, hypermutation might unveil 
autoantibodies during immune responses.
MATERIALS AND METHODS
Flow cytometry. Mouse B cells were purifi  ed from suspensions of spleen 
cells using a RosetteSep murine B cell isolation kit (Stemcell Technologies). 
Antibodies included rat monoclonal antibodies against mCκ (PE; BD 
  Biosciences) and hCκ (FITC; previously available from SouthernBiotech). 
Cells were sorted using either a MoFlo (Dako Cytomation) or a FACS-Aria 
(Becton Dickinson) cytometer. Cytometric analyses were done using a 
LSR II analyzer (Becton Dickinson). Analyses and fi  gures were done with 
FlowJo software.
Immunohistochemistry. For analysis of the total frequency of allelic in-
clusion by immunofl  uorescence and confocal microscopy, total splenic B 
cells from Igκh/m mice were enriched by magnetic bead depletion of non–B 
cells (Stemcell Technologies) and stained with biotin-conjugated goat anti- 
hCk that had been absorbed with mCκ protein (SouthernBiotech), fol-
lowed by streptavidin-conjugated Alexa Fluor 546 (Invitrogen) and rat 
anti-mCk (SouthernBiotech) directly conjugated in-house to Alexa Fluor 
488 (Invitrogen). The cells were adhered to microscope slides and scored 
using a confocal microscope (LSM-510 META; Carl Zeiss MicroImaging, 
Inc.). Analyses for sorted fractions of hCκ+ cells for surface expression 
of mCκ+ were similar, except that the cells were stained with anti-mCκ 
conjugated to alkaline phosphatase (SouthernBiotech), adhered to slides, 
and developed with Alkaline Phosphatase Substrate kit III (Vector Labora-
tories). For analysis of splenic tissue, sections from snap-frozen Igκm/h, 
Igκm/m, and Igκh/h mouse spleens were stained with rat anti-mCκ (Southern-
Biotech) and developed as per the sorted fractions (above). Sections 
were then stained with mouse anti–hCκ-HRP (SouthernBiotech) and 
  developed with Vector NovaRED Substrate kit (Vector Laboratories). 
Analyses were done with a fl  uorescent microscope (Axioplan 2; Carl Zeiss 
MicroImaging, Inc.).
Single-cell RT-PCR. Cells were presorted in bulk using a FACS-Aria 
  cytometer, and single cells were resorted into 96-well plates containing 10 mM 
Tris-HCl with 40 U/μl of RNase inhibitor (Promega) with a MoFlo cy-
tometer fi  tted with a cell dispenser. The plates were immediately frozen on 
dry ice and stored at −80°C until analysis. Each cell was amplifi  ed in a one-
step RT-PCR reaction (OneStep RT-PCR kit; QIAGEN) using a cocktail 
of sense primers specifi  c for the leader region (primers used were as follows: 
5′-A  T  G  G  A  A  T  C  A  C  A  G  R  C  Y  C  W  G  G  T  -3′; 5′-T  T  T  T  G  C  T  T  T  T  C  T  G  G  A  T-
T  Y  C  A  G  -3′; 5′-T  C  T  T  G  T  T  G  C  T  C  T  G  G  T  T  Y  C  C  A  G  -3′; 5′-A  T  T  W  T  C  A-
G  C  T  T  C  C  T  G  C  T  A  A  T  C  -3′; 5′-T  G  C  T  G  C  T  G  C  T  C  T  G  G  G  T  T  C  C  A  G  -3′; 
and 5′-T  C  G  T  G  T  T  K  C  T  S  T  G  G  T  T  G  T  C  T  G  -3′), and antisense primers 
specifi  c for either mCκ (5′-A  G  C  T  C  T  T  G  A  C  G  A  T  G  G  G  T  G  A  A  G  T  T  G  -3′) 
or hCκ (5′-G  T  T  T  C  T  C  G  T  A  G  T  C  T  G  C  T  T  T  G  C  T  C  A  -3′). RT-PCR con-
ditions were as follows: 50°C for 30 min, 95°C for 15 min, followed 
by 39 cycles of 95°C for 1 min, 55°C for 1 min, 72°C for 1 min, and, 
fi  nally, 72°C for 10 min. 1 μl from each RT-PCR reaction was reampli-
fi  ed using nested PCR primers specifi  c for FW1 regions of the various 
Vκ genes (5′-G  C  G  A  A  G  C  T  T  C  C  C  T  G  A  T  C  G  C  T  T  C  A  C  A  G  G  C  A  G  T  G  G  -3′, 
5′-G  C  G  A  A  G  C  T  T  C  C  C  T  G  C  T  C  G  C  T  T  C  A  G  T  G  G  C  A  G  T  G  G  -3′, 5′-G  C  G  A-
A  G  C  T  T  C  C  C  A  K  C  C  A  G  G  T  T  C  A  G  T  G  G  C  A  G  T  G  G  -3′, and 5′-G  C  G  A  A  G-
C  T  T  S  C  C  A  T  C  R  A  G  G  T  T  C  A  G  T  G  G  CAGTGG-3′), and antisense primers 
specifi  c to either mCκ (5′-A  T  C  T  G  G  A  G  G  T  G  C  C  T  C  A  G  T  C  -3′) or hCκ 
(5′-G  T  G  C  T  G  T  C  C  T  T  G  C  T  G  T  C  C  T  G  C  T  C  -3′). Nested PCR reaction 
conditions were as follows: 95°C for 15 min, followed by 39 cycles of 95°C 
for 1 min, 55°C for 1 min, 72°C for 1 min, and a fi  nal 72°C for 10 min. 
PCR products were resolved using 1% Agarose gels, and products were 
purifi  ed (Gel Extraction kit; QIAGEN) and sequenced on an ABI 3730 
capillary sequencer by the Oklahoma Medical Research Foundation DNA 
sequencing core facility.
Analysis of Igκ proteins from hybridomas (ELISA, Western blot, 
and ANA). Hybridomas were produced and subcloned by the Monoclonal 
Antibody Core Facility at the Memorial Sloan-Kettering Cancer Center. Igκ 
splenic B cells from 4-wk-old mice were stimulated for 3 d in fetal calf 
  serum–supplemented RPMI with 25 μg/ml of lipopolysacharide (Sigma-
  Aldrich) and fused to the SP2 cell line. Two separate fusions with diff  erent 
mice produced similar results and were combined herein (58 and 70 clones 
for 128 total Igκm/h hybridomas). Each clone expressing protein or tran-
scripts from both Ig alleles was subcloned in triplicate by limiting dilution to 
verify monoclonality. Clones from which no Igκ expression was detectable 
were discarded. Antibodies were expressed in serum-free RPMI media sup-
plemented with Nutridoma (Roche) and purifi  ed from supernatant using 
Agarose-bead–conjugated L-protein (Pierce Chemical Co.). Capture ELISA 
assays were performed using purifi  ed anti-hCκ or -mCκ (Jackson Immuno-
Research Laboratories) and horse-radish peroxidase (HRP)–conjugated 
anti-hCκ or anti-mCκ (Jackson ImmunoResearch Laboratories). For the 
anti-DNA ELISAs, purifi  ed antibodies were captured on microtiter plates 
coated with 10 g/ml of salmon-sperm double-stranded DNA (Roche). The 
HRP was developed using a HRP detection kit (Bio-Rad Laboratories). All 
ELISA assays were analyzed using a SpectraMax plus microtiter plate reader 
(Invitrogen). Western blots were performed using HRP-conjugated anti-
bodies (Jackson ImmunoResearch Laboratories). Purifi  ed antibodies were 
screened for ANA reactivity using commercially prepared HEp-2 slides JEM VOL. 204, January 22, 2007  159
ARTICLE
(BION Enterprises, Ltd.) and the aforementioned FITC-conjugated anti-
mCκ or -hCκ antibodies. The HEp-2–reactive clones were verifi  ed using 
a commercial ANA assay kit designed to test mouse autoantibodies (The 
Binding Site).
Ribonuclease-protection assays. RNA was isolated from 1 million cells 
for each hybridoma clone using the RNAwiz reagent (Ambion) and treated 
with RNase-free DNase for 15 min at 37°C. The reaction was stopped with 
addition of one twentieth volume of 0.5 M EDTA, followed by heat inacti-
vation of the DNase I for 10 min at 90°C, phenol/chloroform extraction, 
and ETOH precipitation. 5 μg of RNA were used in each of three replicate 
RPA reactions for each hybridoma analyzed. RPA probes were designed as 
described in Fig. S2 and cloned in the PcR2.1 vector containing both T3 
and T7 RNA polymerase promoters. The [32P]UTP-labeled RNA probes 
were generated using the MAXIscript In Vitro Transcription kit (Ambion). 
To ensure full-length probes, each probe was purifi  ed from a 5% polyacryl-
amide/8 M urea gel. RNA probes were eluted overnight at room tempera-
ture from excised bands of the appropriate length with NH4-acetate/1 mM 
EDTA/0.2% SDS, followed by ETOH precipitation and resuspension in 
  diethylpyrocarbonate-treated water at a concentration of 5 × 104 cpm in 10 μl. 
RPA reactions were performed using the RPA III kit (Ambion). All   antisense 
probes were hybridized simultaneously to each sample. Protected fragments 
were resolved using a 5% denaturing polyacrylamide DNA sequencing gel 
and quantifi  ed using a phosphorimager (Storm 840; Molecular Dynamics). 
Protected bands were normalized relative to the Sp2 cell line fusion partner 
OOF mCκ transcript that is produced by each hybridoma to account for 
variations in RNA sample quality.
Online supplemental material. Fig. S1 provides an analysis of the abun-
dance of either allele expressed as measured by immunohistochemistry. 
Fig. S2 is an analysis of transcript expression levels from either Igκ allele. 
Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20061918/DC1.
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